Exact Mass: 410.1689076
Exact Mass Matches: 410.1689076
Found 246 metabolites which its exact mass value is equals to given mass value 410.1689076,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
alpha-Mangostin
Alpha-mangostin is a member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities. It has a role as an antineoplastic agent, an antimicrobial agent, an antioxidant and a plant metabolite. It is a member of xanthones, a member of phenols and an aromatic ether. Mangostin is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug. alpha-Mangostin is a natural product found in Garcinia merguensis, Garcinia cowa, and other organisms with data available. See also: Garcinia mangostana fruit rind (part of). A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities. alpha-Mangostin is found in fruits. alpha-Mangostin is a pigment from Garcinia mangostana (mangosteen Pigment from Garcinia mangostana (mangosteen). alpha-Mangostin is found in fruits. alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM. alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM.
1-Isomangostin
Constituent of Garcinia mangostana (mangosteen). 1-Isomangostin is found in fruits and purple mangosteen. 1-Isomangostin is found in fruits. 1-Isomangostin is a constituent of Garcinia mangostana (mangosteen)
3-Isomangostin
3-Isomangostin is a member of xanthones. 3-Isomangostin is a natural product found in Garcinia morella, Cratoxylum formosum, and other organisms with data available. Constituent of Garcinia mangostana (mangosteen). 3-Isomangostin is found in fruits and purple mangosteen. 3-Isomangostin is found in fruits. 3-Isomangostin is a constituent of Garcinia mangostana (mangosteen). 3-Isomangostin, extracted from Garciniamangostana.L. shell, is a potent MutT homologue 1 (MTH1) inhibitor with an IC50 value of 52?nM. 3-Isomangostin would be an attractive chemical tool for the development of anticancer agents[1]. 3-Isomangostin, extracted from Garciniamangostana.L. shell, is a potent MutT homologue 1 (MTH1) inhibitor with an IC50 value of 52?nM. 3-Isomangostin would be an attractive chemical tool for the development of anticancer agents[1].
Clobetasol
C22H28ClFO4 (410.16600500000004)
Clobetasol is only found in individuals that have used or taken this drug. It is a derivative of prednisolone with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than fluocinonide, it is used topically in treatment of psoriasis but may cause marked adrenocortical suppression. [PubChem]The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Initially, however, clobetasol, like other corticosteroids, bind to the glucocorticoid receptor, which complexes, enteres the cell nucleus and modifies genetic transcription (transrepression/transactivation). D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AD - Corticosteroids, very potent (group iv) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Dulxanthone B
Dulxanthone B is found in fruits. Dulxanthone B is a constituent of the stem bark of Garcinia dulcis (mundu). Constituent of the stem bark of Garcinia dulcis (mundu). Dulxanthone B is found in fruits.
Eremopetasitenin C3
Eremopetasitenin D3 is found in green vegetables. Eremopetasitenin D3 is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). Eremopetasitenin C3 is found in green vegetables.
Clocortolone
C22H28ClFO4 (410.16600500000004)
Clocortolone is only found in individuals that have used or taken this drug. It is a medium potency corticosteroid that is often used as a topical cream for the relief of inflammatory oand pruritic (itching) arising from steroid-responsive dermatoses of the scalp.The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. These enzyme transcriptional changes are mediated by the drug binding first to the glucocorticoid receptor. This complex can migrate to the cell nucleus which then binds to DNA initiating genetic activation and repression of various genes. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Tipredane
C22H31FO2S2 (410.17493979999995)
Tipredane belongs to the family of Sesterterpenes. These are terpenes compsed of five consecutive isoprene units.
Buparlisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Deoxycorticosterone sulfate
1,3,6-Trihydroxy-7-methoxy-2,5-bis(3-methyl-2-butenyl)xanthone
Cochinchinone C
A polycyclic cage that is a prenylated-caged xanthone isolated from Cratoxylum cochinchinense and has been shown to exhibit antimalarial and antioxidant activities.
Rubraxanthone
A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 3, 6 and 8, a geranyl group at position 1 and a methoxy group at position 2. Isolated from Mesua and Garcinia dioica, it exhibits antibacterial and cytotoxic activities.
paxanthonin
A member of the class of xanthones that is 9H-xanthen-9-one substituted by a 2,2-dimethyl-4-(prop-1-en-2-yl)cyclopentyl group at position 2, hydroxy groups at positions 1, 3 and 6 and a methoxy group at position 5. It is isolated from the callus of Hypericum perforatum and exhibits antioxidant and antimicrobial activities.
Pirlimycin
C17H31ClN2O5S (410.16421060000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Cratoxyarborenone E
A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3 and 7, isoprenyl groups at positions 4 and 5 and a methoxy group at position 6. It is isolated from Cratoxylum Sumatranum and exhibits cytotoxicity towards the KB (human oral epidermoid) cancer cell line.
13-Hydroxy-5-methoxy-3,3,10,10-tetramethyl-2,3,11,12-tetrahydro-1H,10H-dipyrano[3,2-a;2,3-i]xanthen-14-on|13-hydroxy-5-methoxy-3,3,10,10-tetramethyl-2,3,11,12-tetrahydro-1H,10H-dipyrano[3,2-a;2,3-i]xanthen-14-one|BR-xanthone A monomethyl ether|Tovophyllin A
1,3,6-trihydroxy-7-methoxy-2-(3,7-dimethyl-2,6-octadienyl)xanthone
(-)-2beta-(2xi,3-epoxy-3-methyl-1-oxobutyl)-2-deoxybruceol
2-Methylbutanoic acid 3-[1-(1,3-benzodioxole-5-yl)-1,2-epoxy-6-methoxy-1,2-dihydrobenzocyclobutene-4-yl]propyl ester
1,5-dihydroxy-8-methoxy-7-(3,3-dimethyl-20-propenyl)-4,4,5-trimethylfurano-[2,3:4,3]-xanthone|inophinnin
3-methoxycheffouxanthone|4-(3,7-dimethyl-2,6-octadienyl)-1,5,8-trihydroxy-3-methoxyxanthone
3-hydroxy-6-methoxy-5-isopropyl-4,5-dihydrofuro[2,3:7,8]-6,6-dimethyl-4,5-dihydropyrano[2,3:1,2]xanthone
1,6-dihydroxy-7-methoxy-8-(3-methylbut-3-enyl)-6,6-dimethyl-4,5-dihydropyrano[23:3,2]xanthone
1,7-dihydroxy-8-methoxy-6-(3-methyl-2-butenyl)-4,4-dimethylfurano-[2,3:3,4]-xanthone|mesuaferrin C
2,3-dihydro-7-hydroxy-2S*,3R*-dimethyl-2-[4-methyl-5-(4-methyl-5-oxo-2,5-dihydro-2-furyl)-3(E)-pentenyl]furo[3,2-c]coumarin|fukanefuromarin J
1-O-hexanoyl-6-O-beta-D-xylopyranosyl-beta-D-glucopyranose|nonioside S
(6aS*,9R*,9aS*)-6a-methyl-9-(2-methylbutyryl)-3-[(1S*,6S*)-6-methyl-2-oxocyclohex-3-enyl]-9,9a-dihydro-6aH-furo[2,3-h]isochromene-6,8-dione|multiformin A
10-cinnamoyloxy-6-methoxy-8,9-epoxythymol isobutyrate
3,3,12,12-Tetramethyl-5-hydroxy-9-methoxy-1,2,3,10,11,12,14-heptahydro-4,7,13-trioxadibenzo[a,j]anthracene-14-one
1,3,5-trihydroxy-6-methoxy-2-(1,1-dimethyl-2-propenyl)-7-(3-methyl-2-butenyl)-9H-xanthen-9-one|Cudrafrutixanthone|cudrafrutixanthone A
1,3,6-Trihydroxy-2,7-bis(3-methyl-2-butenyl)-5-methoxyxanthone
1,4,6-trihydroxy-3-methoxy-2-(3-methyl-2-butenyl)-5-(1,1-dimethyl-prop-2-enyl)xanthone
1-O-(3-methylbut-3-en-1-yl)-6-O-beta-D-glucopyranosyl-beta-D-glucopyranose|3-methyl-3-butenyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|3-methylbut-3-enyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|3-methylbut-3-enyl-6-O-beta-D-glucopyranosyl-beta-D-glucopyranose|3-methylbut-3-enyl6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|nonioside A
Mangostin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.514 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.515 alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM. alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM.
Pergolide mesylate
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Pergolide mesylate (Pergolide methanesulfonate), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptors agonist. Pergolide mesylate can be used for Parkinson's disease and hyperprolactinaemia research[1][2].
1,3,7-trihydroxy-6-methoxy-4,5-bis(3-methylbut-2-enyl)xanthen-9-one
Clobetasol
C22H28ClFO4 (410.16600500000004)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AD - Corticosteroids, very potent (group iv) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2399
Ala Ala Cys Phe
C18H26N4O5S (410.16238260000006)
Ala Ala Phe Cys
C18H26N4O5S (410.16238260000006)
Ala Cys Ala Phe
C18H26N4O5S (410.16238260000006)
Ala Cys Phe Ala
C18H26N4O5S (410.16238260000006)
Ala Phe Ala Cys
C18H26N4O5S (410.16238260000006)
Ala Phe Cys Ala
C18H26N4O5S (410.16238260000006)
Cys Ala Ala Phe
C18H26N4O5S (410.16238260000006)
Cys Ala Phe Ala
C18H26N4O5S (410.16238260000006)
Cys Phe Ala Ala
C18H26N4O5S (410.16238260000006)
Phe Ala Ala Cys
C18H26N4O5S (410.16238260000006)
Phe Ala Cys Ala
C18H26N4O5S (410.16238260000006)
Phe Cys Ala Ala
C18H26N4O5S (410.16238260000006)
Phe Gly Gly Met
C18H26N4O5S (410.16238260000006)
Phe Gly Met Gly
C18H26N4O5S (410.16238260000006)
Phe Met Gly Gly
C18H26N4O5S (410.16238260000006)
Gly Phe Gly Met
C18H26N4O5S (410.16238260000006)
Gly Phe Met Gly
C18H26N4O5S (410.16238260000006)
Gly Gly Phe Met
C18H26N4O5S (410.16238260000006)
Gly Gly Met Phe
C18H26N4O5S (410.16238260000006)
Gly Met Phe Gly
C18H26N4O5S (410.16238260000006)
Gly Met Gly Phe
C18H26N4O5S (410.16238260000006)
Met Phe Gly Gly
C18H26N4O5S (410.16238260000006)
Met Gly Phe Gly
C18H26N4O5S (410.16238260000006)
Met Gly Gly Phe
C18H26N4O5S (410.16238260000006)
2H-Indol-2-one, 1,3-dihydro-7-hydroxy-4-[2-(propylamino)ethyl]- glucuronide
Eremopetasitenin C3
3-Isomangostin
3-Isomangostin, extracted from Garciniamangostana.L. shell, is a potent MutT homologue 1 (MTH1) inhibitor with an IC50 value of 52?nM. 3-Isomangostin would be an attractive chemical tool for the development of anticancer agents[1]. 3-Isomangostin, extracted from Garciniamangostana.L. shell, is a potent MutT homologue 1 (MTH1) inhibitor with an IC50 value of 52?nM. 3-Isomangostin would be an attractive chemical tool for the development of anticancer agents[1].
Tipredane
C22H31FO2S2 (410.17493979999995)
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
butane-1,4-diol,1,3-diisocyanato-2-methylbenzene,hexanedioic acid
Phenol, 2,6-dimethyl-,phosphate (3:1)
C24H27O4P (410.16468720000006)
Pyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione,7-[(dimethylamino)methylene]-6,7-dihydro-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)- (9CI)
1-N,4-N-bis(4-methoxyphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
1H-Indazole-1-propanamide,N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-thienylmethyl)-(9CI)
1-N,4-N-bis(2-methoxyphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
1-N,4-N-bis(3-methoxyphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
C17H26N6O4S (410.17361560000006)
2-Propenoic acid, 2-Methyl-, [1,1-biphenyl]-4,4-diylbis(oxy-2,1-ethanediyl) ester (9CI)
4-butyl-1,2-diphenylpyrazolidine-3,5-dione, compound with 4,5-dihydrothiazol-2-amine (1:1)
TRANS-4-(4-(DIMETHYLAMINO)STYRYL)-1-ME-&
C23H26N2O3S (410.1664046000001)
2,8-Diazaspiro[4.5]decane, 2-(1-methylethyl)-, 2,2,2-trifluoroacetate (1:2)
C15H24F6N2O4 (410.16401759999997)
{(2s)-1-[n-(Tert-Butoxycarbonyl)glycyl]pyrrolidin-2-Yl}methyl (3-Chlorophenyl)acetate
C20H27ClN2O5 (410.16084020000005)
Carmoxirole hydrochloride
Carmoxirole hydrochloride (EMD 45609 hydrochloride) is a selective, peripherally acting dopamine D2 receptor agonist and exhibits antihypertensive activities in vivo[1].
Buparlisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
clocortolone
C22H28ClFO4 (410.16600500000004)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-4beta-propyl-2alpha-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-alpha-D-galacto-octopyranoside
C17H31ClN2O5S (410.16421060000005)
1,3,6-Trihydroxy-7-methoxy-2,5-bis(3-methyl-2-butenyl)xanthone
[2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl]methyl-[(4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]azanium
Egonol-2-methyl butanoate
A fatty acid ester obtained by the formal condensation of (S)-2-methylbutyric acid with egonol. It has been isolated from the fruits of Styrax agrestis.
(+)-(3R,5S)-fluvastatin
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors
N-[4-(4-morpholinyl)phenyl]-2-pyridin-4-yl-4-quinolinecarboxamide
[2-[3-phenyl-2-[(E)-3-phenylprop-2-enoyl]-3,4-dihydropyrazol-5-yl]phenyl] acetate
C26H22N2O3 (410.16303419999997)
N-(2,4-dimethoxyphenyl)-3-(6-methyl-1H-benzimidazol-2-yl)-1-piperidinecarbothioamide
3-(3-ethoxypropyl)-1-[(4-oxo-1H-quinazolin-2-yl)methyl]-1-(phenylmethyl)thiourea
3,4-dihydro-1H-isoquinolin-2-yl-[4-[hydroxy(diphenyl)methyl]-1-triazolyl]methanone
4-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
(6Ar,9S,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline;methanesulfonic acid
3,5-dicyano-4-(dibutylamino)-N-phenylbenzenesulfonamide
N-[3-(2,3-Dimethyl-1H-indol-1-yl)-2-methylpropyl]-3,5-dinitrobenzamide
(2R,5R)-2-(hydroxymethyl)-5-[6-[(1-methoxyindol-3-yl)methylamino]purin-9-yl]oxolan-3-ol
1-Isomangostin
An organic heterotetracyclic compound that is 3,4-dihydro-2H,12H-pyrano[2,3-a]xanthen-12-one substituted by hydroxy groups at positions 5 and 9, a methoxy group at position 10, two methyl groups at position 2, a prenyl group at position 11 and an oxo group at position 12.
(4s,4as,5r,6s,8ar,9ar)-4,9a-dimethoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2z)-3-(methylsulfanyl)prop-2-enoate
5,9-dihydroxy-10-methoxy-1,1,2-trimethyl-7-(3-methylbut-2-en-1-yl)-2h-furo[2,3-c]xanthen-6-one
8-hydroxy-13-methoxy-17,17-dimethyl-15-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione
16-(3,3-dimethyloxirane-2-carbonyl)-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.0²,⁷.0⁹,¹⁸.0¹²,¹⁷]nonadeca-1,3,7,9(18)-tetraen-5-one
1,3,6-trihydroxy-5-methoxy-2,7-bis(3-methylbut-2-en-1-yl)xanthen-9-one
3-[(7s,9r)-7-(2h-1,3-benzodioxol-5-yl)-5-methoxy-8-oxatricyclo[4.3.0.0⁷,⁹]nona-1,3,5-trien-3-yl]propyl (2r)-2-methylbutanoate
(2s)-5,9-dihydroxy-10-methoxy-1,1,2-trimethyl-7-(3-methylbut-2-en-1-yl)-2h-furo[2,3-c]xanthen-6-one
(2s,4r)-n-{2-chloro-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-4-propylpyrrolidine-2-carboximidic acid
C17H31ClN2O5S (410.16421060000005)
2-(2,7-dimethylocta-1,6-dien-1-yl)-1,3,6-trihydroxy-7-methoxyxanthen-9-one
16-hydroxy-10-methoxy-6,6,19,19-tetramethyl-5,13,18-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(22),3,9,11,14,16-hexaen-2-one
6a-methyl-3-(6-methyl-2-oxocyclohex-3-en-1-yl)-9-(2-methylbutanoyl)-9h,9ah-furo[2,3-h]isochromene-6,8-dione
2-(3,7-dimethylocta-2,6-dien-1-yl)-1,3,6-trihydroxy-7-methoxyxanthen-9-one
3-[3,4-dimethoxy-5-(3-methylbut-2-en-1-yl)phenyl]-5,7-dimethoxychromen-4-one
(6as,9r,9as)-6a-methyl-3-[(1s,6s)-6-methyl-2-oxocyclohex-3-en-1-yl]-9-[(2r)-2-methylbutanoyl]-9h,9ah-furo[2,3-h]isochromene-6,8-dione
1,5,6-trihydroxy-3-methoxy-4,7-bis(3-methylbut-2-en-1-yl)xanthen-9-one
4-[3''-(1c-methylbutanoyloxy)propyl]-2-meth-oxy-(3',4'-methylenedioxyphenyl)-1a,5b-di-hydrobenzo-[3,4]-cyclobutaoxirene
{"Ingredient_id": "HBIN009896","Ingredient_name": "4-[3''-(1c-methylbutanoyloxy)propyl]-2-meth-oxy-(3',4'-methylenedioxyphenyl)-1a,5b-di-hydrobenzo-[3,4]-cyclobutaoxirene","Alias": "NA","Ingredient_formula": "C24H26O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6,12-dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-3,4-dihydro-1,10-dioxatetraphen-5-one
6-[(4r)-6,7-dimethoxy-3,4-dihydro-2h-1-benzopyran-4-carbonyl]-5-methoxy-2,2-dimethylchromene
3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propyl 2-methylbutanoate
4,8,9-trihydroxy-2,2,3,3-tetramethyl-6-(3-methylbut-2-en-1-yl)furo[3,2-b]xanthen-5-one
6-(6,7-dimethoxy-3,4-dihydro-2h-1-benzopyran-4-carbonyl)-5-methoxy-2,2-dimethylchromene
2-[2,2-dimethyl-4-(prop-1-en-2-yl)cyclopentyl]-1,3,6-trihydroxy-5-methoxyxanthen-9-one
1,6,7-trihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)xanthen-9-one
4,8-dihydroxy-9-methoxy-2,3,3-trimethyl-7-(3-methylbut-2-en-1-yl)-2h-furo[3,2-b]xanthen-5-one
[(2s)-2-{5-methoxy-4-methyl-2-[(2-methylpropanoyl)oxy]phenyl}oxiran-2-yl]methyl (2e)-3-phenylprop-2-enoate
(2s)-8,9-dihydroxy-4-methoxy-2,3,3-trimethyl-5-(3-methylbut-2-en-1-yl)-2h-furo[2,3-a]xanthen-11-one
(6as,9r,9as)-6a-methyl-3-[(1s,6s)-6-methyl-2-oxocyclohex-3-en-1-yl]-9-(2-methylbutanoyl)-9h,9ah-furo[2,3-h]isochromene-6,8-dione
(5r)-4-[(3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)methyl]-5-methoxy-3-(4-methoxyphenyl)-5h-furan-2-one
(1s,2s,13r)-8-hydroxy-13-methoxy-17,17-dimethyl-15-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione
2-methyl-6-{4-[3-methyl-5-(prop-1-en-1-yl)-1-benzofuran-2-yl]phenoxy}oxane-3,4,5-triol
3,6,8-trihydroxy-2-methoxy-1-(3-methylbut-2-en-1-yl)-5-(2-methylbut-3-en-2-yl)xanthen-9-one
1-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-3,6,8-trihydroxy-2-methoxyxanthen-9-one
4,9a-dimethoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl 3-(methylsulfanyl)prop-2-enoate
3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propyl (2r)-2-methylbutanoate
1,5,8-trihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)xanthen-9-one
(4s,4ar,5r,6s,8ar,9ar)-4,9a-dimethoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2z)-3-(methylsulfanyl)prop-2-enoate
7-(3,7-dimethylocta-2,6-dien-1-yl)-1,5,6-trihydroxy-3-methoxyxanthen-9-one
1,5,7-trihydroxy-4-methoxy-2,8-bis(3-methylbut-2-en-1-yl)xanthen-9-one
(2s,4r)-n-[(1s,2s)-2-chloro-1-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboximidic acid
C17H31ClN2O5S (410.16421060000005)
1-(3,7-dimethylocta-2,6-dien-1-yl)-3,6,8-trihydroxy-2-methoxyxanthen-9-one
1,5,6-trihydroxy-3-methoxy-2-(3-methylbut-2-en-1-yl)-4-(2-methylbut-3-en-2-yl)xanthen-9-one
2-[(1e)-2,7-dimethylocta-1,6-dien-1-yl]-1,3,6-trihydroxy-7-methoxyxanthen-9-one
(12r,15r,16r,17s)-16-[(2s)-3,3-dimethyloxirane-2-carbonyl]-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.0²,⁷.0⁹,¹⁸.0¹²,¹⁷]nonadeca-1,3,7,9(18)-tetraen-5-one
(1s,2s,13r,15s)-8-hydroxy-13-methoxy-17,17-dimethyl-15-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione
1,3,6-trihydroxy-5-methoxy-7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)xanthen-9-one
3-[7-(2h-1,3-benzodioxol-5-yl)-5-methoxy-8-oxatricyclo[4.3.0.0⁷,⁹]nona-1,3,5-trien-3-yl]propyl 2-methylbutanoate
1,3,5-trihydroxy-6-methoxy-7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)xanthen-9-one
3-(2,4-dimethoxyphenyl)-5,7-dimethoxy-6-(3-methylbut-2-en-1-yl)chromen-2-one
11-hydroxy-21-methoxy-7,7,18,18-tetramethyl-2,8,19-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-1(22),3,9,11,14,20-hexaen-13-one
(2r)-7,8-dihydroxy-4-methoxy-2,3,3-trimethyl-5-(3-methylbut-2-en-1-yl)-2h-furo[2,3-a]xanthen-11-one
22-hydroxy-10-methoxy-7,7,18,18-tetramethyl-8,13,17-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,9,11,14,16(21)-hexaen-2-one
(1r,14r)-25-hydroxy-9,15,15-trimethyl-16-oxa-9,24-diazahexacyclo[12.12.0.0²,¹¹.0³,⁸.0¹⁷,²⁶.0¹⁸,²³]hexacosa-2(11),3,5,7,12,17(26),18,20,22,24-decaen-10-one
C26H22N2O3 (410.16303419999997)